XTT-colorimetric assay as a marker of viability in cryoprocessed cardiac valve

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 4, 1997, Pages 1189-1194

  Lu, Jen Her ^a   Chiu, Yung Tsung ^b   Sung, Hsing Wen ^c   Hwang, Betau ^a   Chong, Chuh Khiun ^a   Chen, Shih Ping ^b   Mao, Simon J ^b   Yang, Pin Zen ^b   Chang, Yen ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b Pig Research Institute Taiwan   (Taiwan)

^c NONE

Author keywords

Cardiac valve; Cryoprocessing; XTT colorimetric assay

Indexed keywords

MITOCHONDRIAL ENZYME; OXIDOREDUCTASE; SODIUM 3' [1 (PHENYLAMINOCARBONYL) 3,4 TETRAZOLIUM] BIS(4 METHOXY 6 NITRO)BENZENE SULFONIC ACID HYDRATE; SULFONIC ACID DERIVATIVE; TETRAZOLIUM; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL TISSUE; ARTICLE; COLORIMETRY; CONTROLLED STUDY; CRYOPRESERVATION; ENZYME ACTIVITY; HEART MUSCLE ISCHEMIA; HEART VALVE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; SWINE; TIME;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0031127931     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0354     Document Type: Article

References (23)

1. ABD-ELFATTAH AS, MESSIER RH, DOMKOWSKI PW, JONES JL, ALY HM, CRESCENZO DG, WALACE RB, HOPKINS RA, 1993. Inhibition of adenosine deaminae and nucleoside transport. Utility in a model of homograft cardiac valve preimplantation processing. J Thorac Cardiovasc Surg 105: 1095-1105.
2. AL-JANABI, LAVIN G, NEIROTTIR, 1972. Viability of fresh aortic valve homografts: a quantitative assessment. Thorax 27: 83-87.
3. ARMIGER L, GRANT C, BARRATT-BOYES B, 1995. Biochemical and cellular characteristization of cardiac valve tissue (Letters). J Thorac Cardiovasc Surg 110: 282-284.
4. BANK HL, SCHMEHL MK, 1989. Parameters for evaluation of viability assays: accuracy, precision, specificity, sensitivity, and standardization. Cryobiology 26: 203-211.
5. BROCKBANK KGM, CARPENTER JF, DAWSON P, 1992. Effects of storage temperature on viable bioprosthetic heart valves. Cryobiology 29: 537-542.
6. CALMAN KC, 1974. The prediction of organ viability. Cryobiology 11: 7-12.
7. CRESCENZO D, HILBERT S., BARRICK M., MESSIER R, WALLACE R, HOPKINS R, 1992. Donor heart valves: Electron microscopic and morphometric assessment of cellular injury induced by warm ischemia. J Thorac Cardiovasc Surg 103: 253-258.
8. CURTIL A, LARESE A, CHAMPSAUR G, BETUEL H, 1991. Methyltetrazolium test for cryopreserved cardiac valve viability (Abstract). Cryobiology 28: 565-566.
9. FERRERA R, MARCSEK P, JOSSINET J, DELHOMME G, DURAC G, 1992. Effect of modified St Thomas solution on hypothermic preserved heart (Abstract). Cryobiology 29: 733.
10. FERRERA R, LARESE A, BERTHOD F, GUIDOLLET J, RODRIGUEZ C, DUREAU G, DITTMAR A, 1993. Quantitative reduction of MTT by hearts biopsies in vitro is an index of viability. J Mol Cell Cardiol 25: 1091-1099.
11. HU JF, GILMER L, HOPKINS R, WOLFINBARGER I, 1989. Effects of antibiotics on cellular viability in porcine heart valve tissue. Cardiovasc Res 23: 960-964.
12. KELVIN GM, BROCKBANK M, CARPENTER JF, DAWSON PE, 1992. Effects of storage temperature on viable bioprothetic heart valves. Cryobiology 29: 537-542.
13. LANG SJ, GIODANO MS, CARDON-CARDO C, SUMMERS BD, SAIANO-COICO L, HAJJAR DP 1994. Biochemical and cellular characterization of cardiac valve tissue after cryopreservation or antibiotic preservation. J Thorac Cardiovasc Surg 108: 63-67.
14. LIVI U, ABDULLA AK, PARKER R, OLSEN EJ, Ross DN, 1987. Viability and morphology of aortic and pulmonary homografts. J Thorac Cardiovasc Surg 93: 755-760.
15. MESSIER RH, DOMKOWSKI PW, ALY HM, ABD-ELFATTAH AS, CRESCENZO DG, WALLACE RB, HOPKINS RA, 1992. High energy phosphate depetion in leaflet matric cells during processing of cryopreserved cardiac valves. J Surg Res 52: 483-488.
16. MOCHTAR B, VAN DER KAMP AWM, JONGH EJ, NAUTA J, 1984. Cell survival in canine aortic heart valves stored in nutrient medium. Cardiovasc Res 18: 497-501.
17. MOSMANN T, 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
18. O'BRIEN MF, JOHNSTON N, STAFFORD G, GARDNER M, POHLNER P, MCGIFFIN D, BROSNAN A, DUFFY P, 1988. A study of the cells in the explanted viable cryopreserved allograft valve. J Cardiac Surg 3: 279-287.
19. Ross DN, 1962. Homograft replacement of the aortic valve. Lancet 2: 487-491.
20. ST. LOUIS J, CORCORAN P, RAJAN S, CONTE J, WOLFINBARGER L, HU J, LANGE PL, WANG YN, HILBERT SL, ANALOUEL A, HOPKINS RA, 1991. Effects of warm ischemia following havesting of allograft cardiac valves. Eur J Cardiothorac Surg 5: 458-465.
21. SOUTHARD JH, 1989. Viability assays in organ preservation. Cryobiology 26:232-238.
22. VAN DER KAMP AWM, NAUTA J, 1979. Fibroblast function and the maintenance of the aortic-valve matrix. Cardiovasc Res 13: 167-172.
23. VAN DER KAMP AWM, VISSER WJ, DONGEN JM, NAUTA J, GALJAARD H, 1981. Preservation of aortic heart valves with maintenance of cell viability. J Surg Res 30: 47-56.